1,465
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Hist-Immune signature: a prognostic factor in colorectal cancer using immunohistochemical slide image analysis

ORCID Icon, , , , , , , , , & ORCID Icon show all
Article: 1841935 | Received 22 Sep 2020, Accepted 21 Oct 2020, Published online: 30 Oct 2020

References

  • Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, Macdonald JS, Somerfield MR, Hayes DF, Bast RC. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. JCO. 2006;24(33):5313–8. doi:10.1200/JCO.2006.08.2644.
  • Nagtegaal ID, Quirke P, Schmoll H-J. Has the new TNM classification for colorectal cancer improved care? Nat Rev Clin Oncol. 2011;9(2):119–123. doi:10.1038/nrclinonc.2011.157.
  • Galon J, Pagès F, Marincola FM, Thurin M, Trinchieri G, Fox BA, Gajewski TF, Ascierto PA. The immune score as a new possible approach for the classification of cancer. J Transl Med. 2012;10(1):1,1479–5876-10–1. doi:10.1186/1479-5876-10-1.
  • Fridman WH, Pagès F, Sautès-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 2012;12(4):298–306. doi:10.1038/nrc3245.
  • Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330–337. doi:10.1038/nature11252.
  • Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M, Berger A, Wind P, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006;313(5795):1960–1964. doi:10.1126/science.1129139.
  • Pagès F, Mlecnik B, Marliot F, Bindea G, Ou F-S, Bifulco C, Lugli A, Zlobec I, Rau TT, Berger MD, et al. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study. Lancet. 2018;391(10135):2128–2139. doi:10.1016/S0140-6736(18)30789-X.
  • Yoo S-Y, Park HE, Kim JH, Wen X, Jeong S, Cho N-Y, Gwon HG, Kim K, Lee HS, Jeong S-Y, et al. Whole-slide image analysis reveals quantitative landscape of tumor-immune microenvironment in colorectal cancers. Clin Cancer Res. 2020;26(4):870–881. doi:10.1158/1078-0432.CCR-19-1159.
  • Nearchou IP, Gwyther BM, Georgiakakis ECT, Gavriel CG, Lillard K, Kajiwara Y, Ueno H, Harrison DJ, Caie PD. Spatial immune profiling of the colorectal tumor microenvironment predicts good outcome in stage II patients. Npj Digit Med. 2020;3(1):71. doi:10.1038/s41746-020-0275-x.
  • Nearchou IP, Lillard K, Gavriel CG, Ueno H, Harrison DJ, Caie PD. Automated analysis of lymphocytic infiltration, tumor budding, and their spatial relationship improves prognostic accuracy in colorectal cancer. Cancer Immunol Res. 2019;7(4):609–620. doi:10.1158/2326-6066.CIR-18-0377.
  • Yu K-H, Zhang C, Berry GJ, Altman RB, Ré C, Rubin DL, Snyder M. Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features. Nat Commun. 2016;7(1):12474. doi:10.1038/ncomms12474.
  • Zhang F, Yao S, Li Z, Liang C, Zhao K, Huang Y, Gao Y, Qu J, Li Z, Liu Z. Predicting treatment response to neoadjuvant chemoradiotherapy in local advanced rectal cancer by biopsy digital pathology image features. Clin Transl Med. 2020 Jun;28:ctm2.110. doi:10.1002/ctm2.110.
  • Kather JN, Weis C-A, Bianconi F, Melchers SM, Schad LR, Gaiser T, Marx A, Zöllner FG. Multi-class texture analysis in colorectal cancer histology. Sci Rep. 2016;6(1):27988. doi:10.1038/srep27988.
  • Yu K-H, Berry GJ, Rubin DL, Ré C, Altman RB, Snyder M. Association of Omics features with histopathology patterns in lung adenocarcinoma. Cell Syst. 2017;5(6):620–627.e3. doi:10.1016/j.cels.2017.10.014.
  • Corredor G, Wang X, Zhou Y, Lu C, Fu P, Syrigos K, Rimm DL, Yang M, Romero E, Schalper KA, et al. Spatial architecture and arrangement of tumor-infiltrating lymphocytes for predicting likelihood of recurrence in early-stage non–small cell lung cancer. Clin Cancer Res. 2019;25(5):1526–1534. doi:10.1158/1078-0432.CCR-18-2013.
  • Kather JN, Krisam J, Charoentong P, Luedde T, Herpel E, Weis C-A, Gaiser T, Marx A, Valous NA, Ferber D, et al. Predicting survival from colorectal cancer histology slides using deep learning: A retrospective multicenter study Butte AJ, editor. PLoS Med. 2019;16(1):e1002730. doi:10.1371/journal.pmed.1002730.
  • Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. Br J Surg. 2015;102(3):148–158. doi:10.1002/bjs.9736.
  • Huang Y, Liang C, He L, Tian J, Liang C, Chen X, Ma Z, Liu Z. Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. JCO. 2016;34(18):2157–2164. doi:10.1200/JCO.2015.65.9128.
  • van Dam P-J, van der Stok EP, Teuwen L-A, Van den Eynden GG, Illemann M, Frentzas S, Majeed AW, Eefsen RL, Coebergh van den Braak RRJ, Lazaris A, et al. International consensus guidelines for scoring the histopathological growth patterns of liver metastasis. Br J Cancer. 2017;117(10):1427–1441. doi:10.1038/bjc.2017.334.
  • Otsu N. A threshold selection method from gray-level histograms. IEEE Trans Syst Man Cybern. 1979;9(1):62–66. doi:10.1109/TSMC.1979.4310076.
  • Ruifrok AC, Johnston DA. Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol. 2001;23:291–299.
  • Ihaka R, Gentleman R. R: a language for data analysis and graphics. J Comput Graphical Stat. 1996;5(3):299–314. doi:10.1080/10618600.1996.10474713.
  • Galon J, Angell HK, Bedognetti D, Marincola FM. The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures. Immunity. 2013;39(1):11–26. doi:10.1016/j.immuni.2013.07.008.
  • Laghi L, Bianchi P, Miranda E, Balladore E, Pacetti V, Grizzi F, Allavena P, Torri V, Repici A, Santoro A, et al. CD3+ cells at the invasive margin of deeply invading (pT3–T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study. Lancet Oncol. 2009;10(9):877–884. doi:10.1016/S1470-2045(09)70186-X.
  • Fujiyoshi K, Väyrynen JP, Borowsky J, Papke DJ, Arima K, Haruki K, Kishikawa J, Akimoto N, Ugai T, Lau MC, et al. Tumour budding, poorly differentiated clusters, and T-cell response in colorectal cancer. EBioMedicine. 2020;57:102860. doi:10.1016/j.ebiom.2020.102860.
  • Fridman W-H, Dieu-Nosjean M-C, Pagès F, Cremer I, Damotte D, Sautès-Fridman C, Galon J. The immune microenvironment of human tumors: general significance and clinical impact. Cancer Microenvironment. 2013;6(2):117–122. doi:10.1007/s12307-012-0124-9.
  • Reichling C, Taieb J, Derangere V, Klopfenstein Q, Le Malicot K, Gornet J-M, Becheur H, Fein F, Cojocarasu O, Kaminsky MC, et al. Artificial intelligence-guided tissue analysis combined with immune infiltrate assessment predicts stage III colon cancer outcomes in PETACC08 study. Gut. 2020;69(4):681–690. doi: 10.1136/gutjnl-2019-319292
  • Weissman SM. Personalized medicine: a new horizon for medical therapy. Precis Clin Med. 2018;1(1):1–2. doi:10.1093/pcmedi/pby001.
  • Zhao K, Li Z, Yao S, Wang Y, Wu X, Xu Z, Wu L, Huang Y, Liang C, Liu Z. Artificial intelligence quantified tumour-stroma ratio is an independent predictor for overall survival in resectable colorectal cancer. EBioMedicine. 2020;61:103054. doi:10.1016/j.ebiom.2020.103054.
  • Trabelsi M, Farah F, Zouari B, Jaafoura MH, Kharrat M. An Immunoscore system based on CD3+ and CD8+ infiltrating lymphocytes densities to predict the outcome of patients with colorectal adenocarcinoma. OTT. 2019;12:8663–8673. doi:10.2147/OTT.S211048.